Text reminders may boost statin refills in heart patients

NCT ID NCT07522645

Ongoing Disease control Sponsor: Kaiser Permanente Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jul 07, 2026 · Updated 3 times

Summary

This study will test whether sending reminders by text, email, or secure patient portal messages helps people with heart disease or diabetes refill their statin prescriptions. About 22,000 adults who have not refilled their statin in the last 3 months will receive one of these messages or usual care. Researchers will track who refills within 14 days and may send a second message using a different method if the first one doesn't work.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: behavioral intervention (text messages, secure portal messages, or email reminders)
What this could lead to: If successful, this could show that simple reminders through existing communication channels improve medication adherence, potentially reducing heart attacks and strokes.
What could go wrong: This is a large but early-stage behavioral study, not a drug trial. Results depend on patient engagement and may not apply to other health systems or populations.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ASCVD are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

atherosclerotic cardiovascular disease diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ASCVD DIABETES

Contacts and locations

Locations

Kaiser Permenante Northern California

Pleasant Hill, California, 94588, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.